EP2148878 - NOVEL HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 16.12.2011 Database last updated on 19.10.2024 | Most recent event Tooltip | 16.12.2011 | Withdrawal of application | published on 18.01.2012 [2012/03] | Applicant(s) | For all designated states Merck Canada Inc. 16711 Trans-Canada Highway Kirkland, QC H94 3L1 / CA | [N/P] |
Former [2011/21] | For all designated states Merck Canada Inc. 16711 Trans-Canada Highway Kirland QC H9H 3L1 / CA | ||
Former [2010/05] | For all designated states Merck Frosst Canada Ltd. 16711 Trans-Canada Highway Kirkland, Québec H9H 3L1 / CA | Inventor(s) | 01 /
LACHANCE, Nicolas 16711 Trans-Canada Highway Kirkland, Québec H9H 3L1 / CA | 02 /
LI, Chun, Sing 16711 Trans-Canada Highway Kirkland, Québec H9H 3L1 / CA | 03 /
LECLERC, Jean-Philippe 16711 Trans-Canada Highway Kirkland, Québec H9H 3L1 / CA | 04 /
RAMTOHUL, Yeeman, K. 16711 Trans-Canada Highway Kirkland, Québec H9H 3L1 / CA | [2010/05] | Representative(s) | Buchan, Gavin MacNicol, et al Merck & Co., Inc. European Patent Department Hertford Road Hoddesdon, Hertfordshire EN11 9BU / GB | [N/P] |
Former [2010/05] | Buchan, Gavin MacNicol, et al Merck & Co., Inc. Patent Department Hertford Road Hoddesdon, Hertfordshire EN11 9BU / GB | Application number, filing date | 08733760.6 | 17.04.2008 | [2010/05] | WO2008CA00721 | Priority number, date | US20070925530P | 20.04.2007 Original published format: US 925530 P | [2010/05] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2008128335 | Date: | 30.10.2008 | Language: | EN | [2008/44] | Type: | A1 Application with search report | No.: | EP2148878 | Date: | 03.02.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.10.2008 takes the place of the publication of the European patent application. | [2010/05] | Search report(s) | International search report - published on: | CA | 30.10.2008 | (Supplementary) European search report - dispatched on: | EP | 12.07.2011 | Classification | IPC: | C07D417/04, A61K31/422, A61K31/427, A61K31/433, A61P3/04, A61P3/06, A61P3/10, C07D413/04 | [2010/05] | CPC: |
C07D413/04 (EP,US);
A61P1/16 (EP);
A61P11/00 (EP);
A61P13/12 (EP);
A61P15/08 (EP);
A61P25/00 (EP);
A61P27/02 (EP);
A61P3/00 (EP);
A61P3/04 (EP);
A61P3/06 (EP);
A61P3/10 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
A61P5/50 (EP);
A61P9/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/05] | Title | German: | NEUE HETEROAROMATISCHE VERBINDUNGEN ALS INHIBITOREN VON STEAROYL-COENZYM-A-DELTA-9-DESATURASE | [2010/05] | English: | NOVEL HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE | [2010/05] | French: | NOUVEAUX COMPOSÉS HÉTÉROAROMATIQUES COMME INHIBITEURS DE LA STÉAROYL-COENZYME A DELTA-9 DÉSATURASE | [2010/05] | Entry into regional phase | 20.11.2009 | National basic fee paid | 20.11.2009 | Search fee paid | 20.11.2009 | Designation fee(s) paid | 20.11.2009 | Examination fee paid | Examination procedure | 03.11.2009 | Amendment by applicant (claims and/or description) | 20.11.2009 | Examination requested [2010/05] | 09.12.2011 | Application withdrawn by applicant [2012/03] | Fees paid | Renewal fee | 15.03.2010 | Renewal fee patent year 03 | 06.04.2011 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO2004052869 (HOFFMANN LA ROCHE [CH]) [I] 6-8,11-16 * example -; claim - * | International search | [XP]WO2008024390 (NOVARTIS AG [CH], et al) [XP] 1, 3, 6, 18-23 * claim 1, example 88 (intermediates prepared in parts B and C) *; | [AP]WO2007143824 (MERCK FROSST CANADA LTD [CA], et al) [AP] 1-23 * claim 1 and examples 5, 9 to 17 and 21 *; | [AP]WO2007143823 (MERCK FROSST CANADA LTD [CA], et al) [AP] 1-23 * claim 1 and examples 21, 22, 26, 30 and 31 *; | [AP]WO2007143597 (NOVARTIS AG [CH], et al) [AP] 1, 3, 6, 18-23 * claim 1 and examples 12.1-12.4, 13.1, 13.7, 13.8, 16, 16.1, 16.2 and 17.1 *; | [A]US2007004711 (ZHANG SUOMING [US], et al) [A] 1, 3, 6-12, 14, 18 * claim 1 and examples 155, 180, 188, 195, 200, 202, 211 and 215 *; | [A]WO2006130986 (MERCK FROSST CANADA LTD [CA], et al) [A] 1, 3, 6, 18-23 * claim 1, examples 48 to 55 and 59 to 62 *; | [A]WO9858929 (JANSSEN PHARMACEUTICA NV [BE], et al) [A] 18, 18 * claim 1, tables F-1 to F-5 * |